2009
DOI: 10.1142/6917
|View full text |Cite
|
Sign up to set email alerts
|

Intellectual Property Rights and the Life Science Industries

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
43
0
5

Year Published

2011
2011
2023
2023

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 68 publications
(49 citation statements)
references
References 0 publications
1
43
0
5
Order By: Relevance
“…Methicillin resistance among S. aureus strains has especially increased rapidly in last decades (Ito et al, 2003). Methicillin (2,6-dimethoxyphenyl penicillin) was first developed in 1959 by George Rawlinson and Ralph Batchelor in England (Rolinson et al, 1960;Dutfield, 2009) and released under the name "Celbenin" for the treatment of penicillinresistant S. aureus infections (Knox, 1961). Shortly thereafter in 1961, the first isolation of MRSA was reported in England (Jevons, 1961;Enright et al, 2002).…”
mentioning
confidence: 99%
“…Methicillin resistance among S. aureus strains has especially increased rapidly in last decades (Ito et al, 2003). Methicillin (2,6-dimethoxyphenyl penicillin) was first developed in 1959 by George Rawlinson and Ralph Batchelor in England (Rolinson et al, 1960;Dutfield, 2009) and released under the name "Celbenin" for the treatment of penicillinresistant S. aureus infections (Knox, 1961). Shortly thereafter in 1961, the first isolation of MRSA was reported in England (Jevons, 1961;Enright et al, 2002).…”
mentioning
confidence: 99%
“…Was it before or after they had achieved significant economic growth? Other scholars argue that it was only after developed countries had achieved economic growth that they strengthened their IPR systems [18][19][20][21].…”
Section: Socio-economic Contextmentioning
confidence: 99%
“…Industry had an active and important role in this shift. In fact, there has been a continuous expansion of the role of industry in advocating stronger and broader intellectual property rights in the life sciences (Dutfield 2003). Industry's lobbying activity had a leading role in both the Diamond v. Chakrabarty trial and the passage of the TRIPS agreement (the Agreement on Trade-Related Aspects of Intellectual Property Rights) in 1986.…”
Section: Open Science Tidesmentioning
confidence: 99%